EPITHELIX

Publications

1 2 3 ... 11 Next >
2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 /
A systems toxicology approach for comparative assessment: Biological impact of an aerosol from a candidate modified-risk tobacco product and cigarette smoke on human organotypic bronchial epithelial cultures
2017
Differential Gene Expression Using RNA Sequencing Profiling in a Reconstituted Airway Epithelium Exposed to Conventional Cigarette Smoke or Electronic Cigarette Aerosols
2017

Banerjee Anisha, Haswell Linsey E ... and Minet Emmanuel.

Applied In Vitro Toxicology. February 2017, doi:10.1089/aivt.2016.0024

Differential Gene Expression Using RNA Sequencing Profiling in a Reconstituted Airway Epithelium Exposed to Conventional Cigarette Smoke or Electronic Cigarette Aerosols

The Use of Human 3D Reconstructed Airway Cultures for Tobacco Product Evaluation: Precision Low-Volume Exposures at the Apical Site
2017

Behrsing Holger P., Huang Song, and Constant Samuel.

Applied In Vitro Toxicology. January 2017, doi:10.1089/aivt.2016.0028.

The Use of Human 3D Reconstructed Airway Cultures for Tobacco Product Evaluation: Precision Low-Volume Exposures at the Apical Site

Development of Combining of Human Bronchial Mucosa Models with XposeALI® for Exposure of Air Pollution Nanoparticles
2017

Jie Ji, Anna Hedelin, Maria Malmlöf, Vadim Kessler, Gulaim Seisenbaeva, Per Gerde, Lena Palmberg

PlusOne, January 2017

Development of Combining of Human Bronchial Mucosa Models with XposeALI® for Exposure of Air Pollution Nanoparticles

Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing
2017

Jon Hamma, Kristie Sullivanb, Amy J. Clippingerc, Judy Stricklanda...David Allena

Establishment and characterization of an in vitro human small airway model SmallAir™
2016

Huang S, Boda B, Vernaz J, Ferreira E, Wiszniewski L, Constant S.
 

Establishment and characterization of an in vitro human small airway model (SmallAir™).

Eur J Pharm Biopharm. 2016 Dec 28. pii: S0939-6411(16)30967-5. doi: 10.1016/j.ejpb.2016.12.006.

Assessment of In Vitro COPD Models for Tobacco Regulatory Science: Workshop Proceedings, Conclusions and Paths Forward for In Vitro Model Use
2016

Holger Behrsing, Hans Raabe, Joseph Manuppello, Betsy Bombick, Rodger Curren...Erin Hill.

Assessment of In Vitro COPD Models for Tobacco Regulatory Science: Workshop Proceedings, Conclusions and Paths Forward for In Vitro Model Use. Altern Lab Anim. 2016 May;44(2):129-66.

Metabolic Characterization of Cell Systems Used in In Vitro Toxicology Testing Part VI. Methods and Protocols for Prediction and Evaluation of Drug Metabolism and Drug Interaction Studies
2016

Carolina Garcia-Canton, Emmanuel Minet

Metabolic Characterization of Cell Systems Used in In Vitro Toxicology Testing: Part VIMethods and Protocols for Prediction and Evaluation of Drug Metabolism and Drug Interaction Studies. 15 JUN 2016

Systems Toxicology Part VII. Role of Metabolism in Toxicology and Pharmacology
2016

Marja Talikka, Stephanie Boué, Stefan Frentzel, Ulrike Kogel, Nicolas Sierro, Bjorn Titz, Emilija Veljkovic, Julia Hoeng, Manuel C. Peitsch

Systems Toxicology: Part VII. Role of Metabolism in Toxicology and Pharmacology. 15 JUN 2016

Influence of the Surfactant Tyloxapol on Mucociliary Clearance in Human Respiratory Cystic Fibrosis Cells
2016

Beubler E. · Fischer R. · Untersteiner G. · Strohmaier W. Pharmacology 2016;98:1-3.

Influence of the Surfactant Tyloxapol on Mucociliary Clearance in Human Respiratory Cystic Fibrosis Cells

1 2 3 ... 11 Next >